tirzepatide safety vs semaglutide safety The infographic compares 10 commonly discussed weight-loss medicines. and produce the greatest average loss, but they can cause nausea, vomiting, constipation, gallstones and semaglutide vs tirzepatide for insulin

Nausea, diarrhea, and decreased appetite occur most frequently but typically improve within the first few weeks

It is important to continue following a healthy diet and exercise plan to maintain weight loss results

Overall, as GLP-1RAs become increasingly prescribed, further pharmacovigilance studies are warranted

It is a first-in-class dual agonist that simultaneously activates two distinct hormone receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor

Incretins as Add-on Therapy Use of incretins in dual therapy may be considered after lifestyle and drug monotherapy become insufficient and before -cell function ceases and insulin therapy becomes the only option

However, on the basis of available data, no dosage adjustment for ZOFRAN is recommended for patients on these drugs [see Clinical Pharmacology (12.3)]